BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 14666799)

  • 21. Update on treatment of uterine sarcoma.
    Nam JH; Park JY
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
    Coquard R; Romestaing P; Ardiet JM; Mornex F; Sentenac I; Gérard JP
    Bull Cancer; 1997 Jun; 84(6):625-9. PubMed ID: 9295866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of surgery and treatment trends in uterine sarcoma.
    Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
    Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
    Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-five years' clinical experience with placental site trophoblastic tumors.
    Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
    J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Squamous cell carcinoma of the uterine cervix at the Dakar Cancer Institute].
    Dem A; Dieng MM; Traoré B; Gaye M; Diop M; Touré P
    Sante; 2008; 18(1):31-3. PubMed ID: 18684688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine sarcoma: prognostic factors and treatment evaluation.
    Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
    Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
    Liao Q; Wang J; Han J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic approach in sarcoma of corpus uteri].
    Bokhman IaV; Urmancheeva AF; Gershanovich ML; Zel'dovich DR; Kutusheva GF
    Vopr Onkol; 1997; 43(6):645-50. PubMed ID: 9479369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.